1. Home
  2. USNA vs PCRX Comparison

USNA vs PCRX Comparison

Compare USNA & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo USANA Health Sciences Inc.

USNA

USANA Health Sciences Inc.

N/A

Current Price

$15.03

Market Cap

397.1M

Sector

Health Care

ML Signal

N/A

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USNA
PCRX
Founded
1992
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.1M
1.1B
IPO Year
1996
2010

Fundamental Metrics

Financial Performance
Metric
USNA
PCRX
Price
$15.03
$25.42
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$30.25
AVG Volume (30 Days)
203.7K
416.5K
Earning Date
05-05-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
$1,060,902,000.00
$541,533,000.00
Revenue This Year
$3.90
$6.78
Revenue Next Year
$6.21
$8.54
P/E Ratio
N/A
$136.21
Revenue Growth
N/A
26.04
52 Week Low
$12.57
$18.80
52 Week High
$31.15
$27.66

Technical Indicators

Market Signals
Indicator
USNA
PCRX
Relative Strength Index (RSI) 45.09 48.87
Support Level $12.57 $24.61
Resistance Level $20.84 $26.93
Average True Range (ATR) 0.63 0.66
MACD 0.41 0.04
Stochastic Oscillator 65.02 52.92

Price Performance

Historical Comparison
USNA
PCRX

About USNA USANA Health Sciences Inc.

Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: